ConAgra Brands, Inc. – Consensus Indicates Potential 4.8% Upside

DirectorsTalk Interviews

ConAgra Brands, Inc. with ticker code (CAG) now have 14 analysts covering the stock. The analyst consensus points to a rating of ‘Hold’. The range between the high target price and low target price is between 40 and 32 with the average target price sitting at 35.96. With the stocks previous close at 34.32 this now indicates there is a potential upside of 4.8%. The 50 day moving average now sits at 34.48 and the 200 moving average now moves to 33.97. The company has a market cap of $16,519m. You can visit the company’s website by visiting: https://www.conagrabrands.com

The potential market cap would be $17,309m based on the market concensus.

Conagra Brands, Inc., together with its subsidiaries, operates as a consumer packaged goods food company in North America. The company operates in four segments: Grocery & Snacks, Refrigerated & Frozen, International, and Foodservice. The Grocery & Snacks segment primarily offers shelf stable food products through various retail channels in the United States. The Refrigerated & Frozen segment provides temperature-controlled food products through various retail channels in the United States. The International segment offers food products in various temperature states through retail and foodservice channels outside of the United States. The Foodservice segment offers branded and customized food products, including meals, entrees, sauces, and various custom-manufactured culinary products packaged for restaurants and other foodservice establishments in the United States. The company sells its products under the Birds Eye, Duncan Hines, Healthy Choice, Marie Callender’s, Reddi-wip, Slim Jim, Angie’s BOOMCHICKAPOP, Duke’s, Earth Balance, Gardein, and Frontera brands. The company was formerly known as ConAgra Foods, Inc. and changed its name to Conagra Brands, Inc. in November 2016. Conagra Brands, Inc. was founded in 1861 and is headquartered in Chicago, Illinois.

Share on:

Latest Company News

Genflow Biosciences reports continued SIRT6 progress in first half of 2026

Genflow Biosciences reported positive interim and three-month follow-up results from its SLAB canine trial, expanded animal health partnerships, secured a fully funded LNP collaboration with Acuitas Therapeutics and strengthened its SIRT6 patent portfolio.

Real Estate Credit Investments (RECI) FY’26 results: High yield, clear path to dividend cover

Real Estate Credit Investments maintained its 3p quarterly dividend, offering a 10.3% yield, while outlining routes to restore dividend cover. Credit performance remains strong, leverage is conservative and the shares continue to trade at a substantial discount to NAV.

RM Assessment targets expanding demand for digital exams

RM Assessment is positioned to benefit as schools and awarding bodies adopt more digital and hybrid examination systems.

Drax takes control of Aldi’s UK EV charging network

Drax will operate and expand around 1,200 electric vehicle chargers across Aldi’s UK store network.

Energy strength and resilient trading updates support the FTSE 100

Higher oil prices and resilient company updates supported a steadier outlook for the FTSE 100.

AI leadership gives emerging markets a stronger strategic position

Emerging markets are gaining a more important role in the global artificial intelligence economy, led by major Asian semiconductor companies with strong positions in advanced computing infrastructure.

    Search